MortaparibPlus-induced cytotoxicity to cancer cells is mediated by multiple mechanisms that included the inhibition of PARP1, up-regulation of p73, and down-regulation of mortalin and CARF proteins that play critical roles in carcinogenesis. The gene discussed is HSPA9; the disease is cancer.